A precision medicine approach to the myelodysplastic syndrome with isolated deletion 5q, 50 years after its discovery.
Roncador M, Bernard E, Hasserjian R, Boultwood J, Elena C, Gallì A, Gurnari C, Mecucci C, Michaux L, Mittelman M, Sarchi M, Travaglino E, McLornan DP, Ogawa S, Papaemmanuil E, Hellström Lindberg E, Malcovati L, Cazzola M.
Blood. 2025 Oct 16;146(16):1883-1896. doi: 10.1182/blood.2025028619.
Age, Blasts, Performance Status and Lenalidomide Therapy Influence the Outcome of Myelodysplastic Syndrome With Isolated Del(5q): A Study of 58 South American Patients.
Azevedo RS, Belli C, Bassolli L, Ferri L, Perusini MA, Enrico A, Pereira T, Junior W, Buccheri V, Pinheiro RF, Magalhaes SM, Schuster S, Castelli JB, Traina F, Rocha V, Velloso E.
Clin Lymphoma Myeloma Leuk. 2022 Jan;22(1):e1-e6. doi: 10.1016/j.clml.2021.07.026. Epub 2021 Jul 25.
Images from the Haematologica Atlas of Hematologic Cytology: myelodysplastic syndrome with isolated del(5q).
Invernizzi R.
Haematologica. 2022 Oct 1;107(10):2285. doi: 10.3324/haematol.2022.281643.
Competitive evolved sub-clonal BCR::ABL1 and novel MSI2::PC fusion genes in myelodysplastic syndrome with isolated del(5q).
Zhang Y, Liu Y, Wang T, Wang H, Chen X, Cao P, Ma X, Liu M, Xu P, Bi H, Pan J, Jiang Y, Li X, Wang W, Liu H.
Hematol Oncol. 2023 Feb;41(1):178-181. doi: 10.1002/hon.3095. Epub 2022 Nov 1.
Gaucher disease and myelodysplastic syndrome with isolated del(5q).
Villarrubia J, Rodríguez-Gambarte JD, Abalo L, Vallés A, Alonso-Domínguez JM, Velasco-Rodríguez D.
Br J Haematol. 2014 Apr;165(2):164. doi: 10.1111/bjh.12798. Epub 2014 Feb 24.
[Myelodysplastic syndrome classification].
Ghariani I, Braham N, Hassine M, Kortas M.
Ann Biol Clin (Paris). 2013 Mar-Apr;71(2):139-44. doi: 10.1684/abc.2013.0804.
Van den Berghe's 5q- syndrome and myelodysplastic syndrome with isolated del(5q).
Lima DS, Costa PT, Matos DM.
Rev Bras Hematol Hemoter. 2015 Nov-Dec;37(6):420-2. doi: 10.1016/j.bjhh.2015.08.001. Epub 2015 Sep 4.
Collapsing Glomerulopathy in a Patient With Myelodysplastic Syndrome With Isolated del(5q): A Case Report.
Naruemon N, Iamsai P, Ounpanyo P, Cheunsuchon B, Vongchaiudomchoke T.
Kidney Med. 2025 Sep 26;7(12):101127. doi: 10.1016/j.xkme.2025.101127. eCollection 2025 Dec.
Treatment of myelodysplastic syndrome with isolated del(5q) including bands q31-q33 with a combination of all-trans-retinoic acid and tocopherol-alpha: a phase II study.
Giagounidis AA, Haase S, Germing U, Schlegelberger B, Wilkens L, Büsche G, Kreipe HH, Wysk J, Grips KH, Grabenhorst U, Rothmann F, Lübbert M, Ganser A, Aivado M, Heinsch M, Aul C.
Ann Hematol. 2005 Jun;84(6):389-94. doi: 10.1007/s00277-005-1027-3. Epub 2005 Mar 23.
Genome-wide miRNA profiling in myelodysplastic syndrome with del(5q) treated with lenalidomide.
Merkerova MD, Krejcik Z, Belickova M, Hrustincova A, Klema J, Stara E, Zemanova Z, Michalova K, Cermak J, Jonasova A.
Eur J Haematol. 2015 Jul;95(1):35-43. doi: 10.1111/ejh.12458. Epub 2014 Nov 11.
